NCT02315534 A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT02311920 Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Status COMPLETED Phase PHASE1
NCT02308527 Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children Status COMPLETED Phase PHASE2
NCT02287428 Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02263105 Efficacy and Tolerability of Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas Status COMPLETED Phase PHASE2
NCT02227901 Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT02209948 Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma. Status COMPLETED Phase PHASE2
NCT02209428 A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas Status UNKNOWN Phase PHASE2
NCT02179086 Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02177578 Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02168270 Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma Status TERMINATED Phase PHASE1
NCT02152982 Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02116777 Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02085304 Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM Status TERMINATED Phase PHASE1/PHASE2
NCT02065466 Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases Status WITHDRAWN Phase PHASE1/PHASE2
NCT02052648 Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02049593 PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02046187 Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE1/PHASE2